Table 4 of Aweidah, Mol Vis 2021; 27:588-600.


Table 4. Comparison of different characteristics between the c.1663-1205G>A deep intronic CNGB3 variant and the other CNGB3 mutations causing achromatopsia.

Characteristics Patients with CNGB3 c.1663-1205G>A
(Mean±SD; Mean±95% CI) Patients with other CNGB3 mutations
(Mean±SD; Mean±95% CI) P value
Age at diagnosis (years) 7.35±7.93; 7.35±3.77 6.42±5.86; 6.42±2.71 p=0.70
Age at first ERG (years) 7.53±8.26; 7.53±4.18 7.58±7.99; 7.58±3.69 p=0.99
Age at the last included ERG (years) 12.69±9.69; 12.69±5.27 15.77±13.43; 15.77±6.80 p=0.51
Age at last included visual acuity (years) 18.75±12.21; 18.75±5.99 20.14±12.02; 20.14±6.30 p=0.76
Current age (years) 22.82±12.45; 22.82±5.92 27.22±17.03; 27.22±7.87 p=0.41
Sex 9 Males, 8 Females 9 Males, 9 Females  
Visual acuity 0.15±0.07; 0.15±0.034 0.092±0.053; 0.092±0.028 p=0.0215
Mean Spherical equivalent§ −0.58±3.83; −0.58±1.88 +1.45±2.00; +1.45±1.01 p=0.088
ffERG Cone- Rod response a-wave (μV)§ 134.94±50.15; 134.94±34.75 121.94±37.30; 121.94±25.85 p=0.59
ffERG Cone- Rod response b-wave (μV)§ 258.81±51.52; 258.81±35.70 266.19±37.32; 266.19±25.86 p=0.76
ffERG Rod response (b-wave; μV)§ 221.36±50.85; 221.36±37.67 225.43±68.95; 225.43±51.08 p=0.91